phosphorylcholine

CAS No. 107-73-3

phosphorylcholine ( Phosphocholine chloride )

Catalog No. M20513 CAS No. 107-73-3

Phosphorylcholine is an antigenic cell-surface component found on many commensal and pathogenic bacteria that reside in the upper airway.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 37 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    phosphorylcholine
  • Note
    Research use only not for human use.
  • Brief Description
    Phosphorylcholine is an antigenic cell-surface component found on many commensal and pathogenic bacteria that reside in the upper airway.
  • Description
    Phosphorylcholine is an antigenic cell-surface component found on many commensal and pathogenic bacteria that reside in the upper airway.
  • Synonyms
    Phosphocholine chloride
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    107-73-3
  • Formula Weight
    219.6
  • Molecular Formula
    C5H15ClNO4P
  • Purity
    >98% (HPLC)
  • Solubility
    H2O:150 mg/mL (683.06 mM)
  • SMILES
    [Cl-].C[N+](C)(C)CCOP(O)(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lawton J M Habib M Ma B et al. The effect of cationically-modified phosphorylcholine polymers on human osteoblasts in vitro and their effect on bone formation in vivo[J]. Journal of Materials Science: Materials in Medicine 2017 28(9):144.
molnova catalog
related products
  • Thalidomide-O-amido-...

    Thalidomide-O-amido-C6-NH2 TFA, a synthesized E3 ligase ligand-linker conjugate containing a Thalidomide-based cereblon ligand and a linker.

  • 3-Methoxytyramine hy...

    3-Methoxytyramine hydrochloride is an inactive metabolite of dopamine which can activate trace amine associated receptor 1 (TAAR1).

  • NMS-P937

    NMS-P937 (NMS1286937), an oral, specific Polo-like Kinase 1 (PLK1) inhibitor, is with IC50 of 2 nM. The specificity of NMS-P937 forPLK1 is 5000-fold higher over PLK2/PLK3.